Latest press releases
LITMUS – Progress towards diagnosing and better treating liver disease
A pioneering European research project, designed to develop new diagnostic tests to assess patients with Non-Alcoholic Fatty Liver Disease (NAFLD) has expanded giving access to more patients. Incorporating several new partners also…
EASL Governing Board appoints Ben Hainsworth as incoming Managing Director
Starting September 2019 Hainsworth will serve as the interface between the EASL Governing Board and the organisation`s Geneva and Brussels operations, ensuring high quality and effective implementation of the Governing Board`s policies…
Journal of Hepatology achieves best ranked publication on liver disease
GENEVA, Switzerland Last week, ClarivateTM Analytics released the 2019 update of its Journal Citation Reports©, including the much anticipated 2018 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology achieved unprecedented…
Genetic analysis has potential to transform diagnosis and treatment of adults with liver disease of unknown cause
Whole-exome sequencing successfully diagnosed genetic cause of liver disease in one in four adults and could play a key role in timely diagnosis and treatment of adults with liver disease of unknown…
Treatment with high doses of albumin improves cardiac function and reduces systemic inflammation in patients with decompensated cirrhosis
According to a study conducted by the EF-Clif published in Gastroenterology This study has shown for the first time that the administration of albumin at high doses has an immunomodulatory effect both…
The WHO guidelines for chronic hepatitis B fail to detect half of the patients in need of treatment in Ethiopia
- 1
- 2